Page last updated: 2024-09-02

ecteinascidin 743 and Skin Ulcer

ecteinascidin 743 has been researched along with Skin Ulcer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demetri, GD; George, S; Hartzell, TL; Morgan, J; Orgill, DP; Polson, K; Sinha, I; Theman, TA1

Reviews

1 review(s) available for ecteinascidin 743 and Skin Ulcer

ArticleYear
Recognition of a new chemotherapeutic vesicant: trabectedin (ecteinascidin-743) extravasation with skin and soft tissue damage.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Nov-20, Volume: 27, Issue:33

    Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Catheterization, Central Venous; Device Removal; Dioxoles; Drainage; Extravasation of Diagnostic and Therapeutic Materials; Female; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Irritants; Leiomyosarcoma; Necrosis; Severity of Illness Index; Skin Ulcer; Soft Tissue Injuries; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome

2009